Histone lactylation induces cisplatin resistance in ovarian cancer via improving homologous recombination repair

被引：0
|
作者：
Sun, Chenggong [1 ]
Zhang, Qing [1 ]
Teng, Qiuli [1 ]
Qiu, Chunping [1 ]
Ma, Xinyue [1 ]
Yuan, Cunzhong [1 ]
Wu, Huan [1 ]
Kong, Beihua [1 ]
Song, Kun [1 ]
机构：
[1] Shandong Univ, Qilu Hosp, Obstet & Gynecol, Jinan, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.372
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP309
引用
收藏
页码：A204 / A204
页数：1
相关论文
共 50 条
  • [31] ENHANCED DNA-REPAIR AND RESISTANCE TO CISPLATIN IN HUMAN OVARIAN-CANCER
    LAI, GM
    OZOLS, RF
    SMYTH, JF
    YOUNG, RC
    HAMILTON, TC
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) : 4597 - 4600
  • [32] Homologous recombination proficiency in ovarian and breast cancer patients
    Justin Fortune Creeden
    Nisha S. Nanavaty
    Katelyn R. Einloth
    Cassidy E. Gillman
    Laura Stanbery
    Danae M. Hamouda
    Lance Dworkin
    John Nemunaitis
    BMC Cancer, 21
  • [33] Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
    Hugh A. Nicholson
    Lynne Sawers
    Rosemary G. Clarke
    Kevin J. Hiom
    Michelle J. Ferguson
    Gillian Smith
    British Journal of Cancer, 2022, 127 : 1340 - 1351
  • [34] Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
    Nicholson, Hugh A.
    Sawers, Lynne
    Clarke, Rosemary G.
    Hiom, Kevin J.
    Ferguson, Michelle J.
    Smith, Gillian
    BRITISH JOURNAL OF CANCER, 2022, 127 (07) : 1340 - 1351
  • [35] Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer
    Tzu-Ting Huang
    Sandra Sczerba Burkett
    Mayank Tandon
    Tomomi M. Yamamoto
    Nitasha Gupta
    Benjamin G. Bitler
    Jung-Min Lee
    Jayakumar R. Nair
    Oncogene, 2022, 41 : 5020 - 5031
  • [36] Micelle encapsulation zinc-doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair
    Yi, Jingyan
    Luo, Xin
    Xing, Jinshan
    Gedanken, Aharon
    Lin, Xiukun
    Zhang, Chunxiang
    Qiao, Gan
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (03)
  • [37] Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer
    Huang, Tzu-Ting
    Burkett, Sandra Sczerba
    Tandon, Mayank
    Yamamoto, Tomomi M.
    Gupta, Nitasha
    Bitler, Benjamin G.
    Lee, Jung-Min
    Nair, Jayakumar R.
    ONCOGENE, 2022, 41 (46) : 5020 - 5031
  • [38] Homologous recombination proficiency in ovarian and breast cancer patients
    Creeden, Justin Fortune
    Nanavaty, Nisha S.
    Einloth, Katelyn R.
    Gillman, Cassidy E.
    Stanbery, Laura
    Hamouda, Danae M.
    Dworkin, Lance
    Nemunaitis, John
    BMC CANCER, 2021, 21 (01)
  • [39] Exploiting Homologous Recombination Repair Defects in Cancer Cells
    Issaeva, N.
    Thomas, H. D.
    Pedley, N.
    Djurenovic, T.
    Lundin, C.
    Gubanova, E.
    Sleeth, K.
    Stoimenov, I
    Chatzakos, V
    Zdzienicka, M. Z.
    Curtin, N. J.
    Helleday, T.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (07) : 544 - 544
  • [40] Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
    Jonsson, Jenny-Maria
    Baath, Maria
    Bjornheden, Ida
    Sahin, Irem Durmaz
    Masback, Anna
    Hedenfalk, Ingrid
    CANCERS, 2021, 13 (02) : 1 - 15
12345